<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.2 20060430//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Nucl Recept Signal</journal-id><journal-id journal-id-type="publisher-id">NURSA</journal-id><journal-title>Nuclear Receptor Signaling</journal-title><issn pub-type="epub">1550-7629</issn><publisher><publisher-name>The Nuclear Receptor Signaling Atlas</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1621/nrs.04009</article-id><article-categories><subj-group subj-group-type="heading"><subject>Perspective</subject></subj-group></article-categories><title-group><article-title>The orphan Rev-erb nuclear receptors: a link between metabolism, circadian rhythm and inflammation? </article-title><alt-title>Rev-erb nuclear receptors</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ramakrishnan</surname><given-names>Sathiya N.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Muscat</surname><given-names>George E.O.</given-names></name><xref ref-type="corresp" rid="cor1">&#x02709;</xref></contrib></contrib-group><aff>Institute for Molecular Bioscience, Division of Molecular Genetics and Development, The University of Queensland, St. Lucia, Australia </aff><author-notes><corresp id="cor1"><label>&#x02709;</label>Corresponding author <email>g.muscat@imb.uq.edu.au</email></corresp></author-notes><pub-date pub-type="collection"><year>2006</year></pub-date><pub-date pub-type="epub"><day>28</day><month>4</month><year>2006</year></pub-date><volume>4</volume><elocation-id>e009</elocation-id><history><date date-type="received"><day>3</day><month>8</month><year>2005</year></date><date date-type="accepted"><day>10</day><month>3</month><year>2006</year></date></history><copyright-statement>Copyright &#x000a9; 2006, Ramakrishnan and Muscat. This is an open-access article distributed under the terms of the Creative Commons Non-Commercial Attribution License, which permits unrestricted non-commercial use distribution and reproduction in any medium, provided the original work is properly cited. </copyright-statement><copyright-year>2006</copyright-year><abstract><p>Nuclear hormone receptors (NRs) function as ligand dependent DNA binding proteins that translate physiological/nutritional signals into gene regulation. Dysfunctional NR signaling leads to many disorders in reproduction, inflammation, and metabolism. The opportunity to identify novel regulatory pathways in the context of human health and disease drives the challenge to unravel the biological function of the &#x0201c;orphan nuclear hormone receptors&#x0201d;. For example, the Rev-erb (NR1D) subgroup (Rev-erb&#x003b1;/NR1D1 and Rev-erb&#x003b2;/NR1D2) of orphan NRs are transcriptional silencers and negative regulators of ROR&#x003b1; mediated trans-activation. The NR1D subgroup is highly enriched in peripheral tissues with onerous energy demands including skeletal muscle, brown and white adipose, brain, liver and kidney. This alludes to the involvement of this subgroup in metabolism. In this context, Rev-erb&#x003b1;-/- mice have a dyslipidemic phenotype. Recent studies in vascular smooth and skeletal muscle cells also suggest that the NR1D subgroup modulates inflammation by regulating I&#x003ba;B&#x003b1;/NF&#x003ba;B dependent gene expression. Rev-erb&#x003b1; has been identified as a critical regulator (and target) of circadian rhythm, a factor in blood pressure control and inflammation. Finally, two recent reports have demonstrated: (i) lithium mediated regulation of Rev-erb&#x003b1; stability and (ii) E75 (the Drosophila orthologue of human Rev-erb&#x003b1;) is tightly bound by heme, and functions as a &#x0201c;gas sensor&#x0201d; through interaction with CO/NO and interferes with the repression of DHR3 (the Drosophila orthologue of human ROR&#x003b1;). In conclusion, the role of these receptors at the cross-roads of metabolism, inflammation, and circadian cycling underscores the importance of understanding the organ-specific function of the NR1D subgroup in homeostasis.</p></abstract></article-meta></front><body><sec><title>The NR1D subgroup of orphan NRs, Rev-erb&#x003b1; (NR1D1) and Rev-erb&#x003b2; (NR1D2)</title><p>All members of the NR superfamily display a highly conserved structural organisation with an amino terminal AB region (that encodes activation function 1, AF-1); followed by the C-region which encodes the DNA binding domain (DBD); a linker region D and the C-terminal E region. The DE region encodes the ligand binding domain (LBD), and a transcriptional domain (in helix 12), denoted as activation function 2 (AF-2) [<xref rid="r70" ref-type="bibr">Gronemeyer et al., 2004</xref>].</p><p>The Rev-erb/NR1D subgroup contains two members, Rev-erb&#x003b1; (NR1D1;[<xref rid="r81" ref-type="bibr">Lazar et al., 1989</xref>]) and Rev-erb&#x003b2; (NR1D2;[<xref rid="r83" ref-type="bibr">Dumas et al., 1994</xref>; <xref rid="r82" ref-type="bibr">Retnakaran et al., 1994</xref>]). The Rev-erbs, and retinoid related orphan receptors (RORs; [<xref rid="r84" ref-type="bibr">Giguere et al., 1994</xref>; <xref rid="r47" ref-type="bibr">Laitinen and Staels, 2003</xref>] bind as monomers to the consensus NR half-site motif, flanked by an 6bp AT-rich sequence (A/T)<sub>6</sub> PuGGTCA, or as a homodimer to a direct repeat of the core motif separated by 2 bp. Although these receptors are closely related, and bind to the same motif, they function in an opposing manner. The NR1D subgroup function as dominant transcriptional silencers, and they repress trans-activation mediated by ROR&#x003b1; [<xref rid="r4" ref-type="bibr">Forman et al., 1994</xref>]. Interestingly, ROR&#x003b1; activates Rev-erb&#x003b1; transcription [<xref rid="r76" ref-type="bibr">Delerive et al., 2002</xref>; <xref rid="r99" ref-type="bibr">Raspe et al., 2002b</xref>], and Rev-erb&#x003b1; represses its own transcription [<xref rid="r5" ref-type="bibr">Adelmant et al., 1996</xref>].</p><p>Homology modeling of the putative LBDs of the NR1D subgroup suggested that the pocket is occupied by bulky side chains, and the small residual cavity could not &#x0201c;accommodate&#x0201d; a classical ligand. Concordantly, NR1D1 and 2 are the only members of the superfamily that do not encode helix 12 and an AF-2 domain [<xref rid="r77" ref-type="bibr">Renaud et al., 2000</xref>]. However, the existence of a novel small molecular regulator cannot be precluded. Molecular modeling also revealed a very hydrophobic surface due to the absence of H12, exposing residues from H3, loop 3-4, H4, and H11 that mediate corepressor recruitment.</p></sec><sec><title>Rev-erbs and lipid metabolism</title><p>Rev-erb&#x003b1; has been shown to be involved in repressing rat apoA1 gene expression [<xref rid="r9" ref-type="bibr">Vu-Dac et al., 1998</xref>]. <italic>in vivo</italic> studies have shown that apoA1 reduces free cholesterol accumulation in atherosclerotic lesions of ApoE-deficient mice. Moreover, human Rev-erb&#x003b1; and &#x003b2; specifically repress apoCIII gene expression in rats [<xref rid="r12" ref-type="bibr">Coste and Rodriguez, 2002</xref>] and humans [<xref rid="r13" ref-type="bibr">Raspe et al., 2002a</xref>]. ApoCIII is a component of HDL and VLDL that regulates triglyceride levels and lipoprotein lipase activity. In this context Rev-erb&#x003b1; null mutant mice [<xref rid="r100" ref-type="bibr">Chomez et al., 2000</xref>] have elevated VLDL triglyceride and apoCIII levels [<xref rid="r13" ref-type="bibr">Raspe et al., 2002a</xref>]. It is interesting to note that plasma triglyceride and apoC-III protein concentrations in staggerer (sg/sg) mice, homozygous for a deletion in the ROR&#x003b1; gene, were significantly lower than in wild type littermates [<xref rid="r47" ref-type="bibr">Laitinen and Staels, 2003</xref>]. This is in agreement with the repression and activation of apoCIII gene expression by Rev-erb&#x003b1; and ROR&#x003b1;, respectively. Moreover, it highlights the regulatory crosstalk between Rev-erb&#x003b1; and ROR&#x003b1; in the context of the blood lipid profile.</p><p>Hypolipidemic fibrate drugs increase Rev-erb&#x003b1; expression in human liver cells [<xref rid="r96" ref-type="bibr">Gervois et al., 1999</xref>]. Interestingly, the fibrate mediated activation occurs at the transcriptional level in a PPAR&#x003b1; dependent manner. The mechanism involves a previously characterized Rev-erb&#x003b1; response element; a unique DR2 element whose 5&#x02019; region is flanked by AT-rich sequence. Rev-erb&#x003b1; and PPAR&#x003b1; compete for binding to this response element in the Rev-erb&#x003b1; promoter. Moreover, Rev-erb&#x003b1; has been shown to modulate hydratase-dehydrogenase expression, a key gene involved in peroxisomal &#x003b2;-oxidation pathway through repression of PPAR&#x003b1;-dependent transactivation [<xref rid="r109" ref-type="bibr">Kassam et al., 1999</xref>]. Similarly, the mechanisms involved direct binding to a PPRE, however, the Rev-erb&#x003b1; and PPAR&#x003b1; binding characteristics to the response element were distinct. Furthermore, fibrates regulate apoA1 gene expression in a species specific manner. For example, fibrates increase and decrease apoA1 expression in humans and rats respectively. Firstly, the repression of apoA1 expression in fibrates is due to a 3 nucleotide difference in the rat promoter that produces a non-functional PPAR&#x003b1; response element. Secondly, the rat but not the human promoter harbors a Rev-erb&#x003b1; response element that mediates Rev-erb&#x003b1; dependent repression in the presence of fibrates. These studies underscore the crosstalk between Rev-erb&#x003b1; and PPAR&#x003b1; in the control of lipid homeostasis.</p><p>Rev-erb&#x003b1; and &#x003b2; are regulated in a biphasic manner during DMI (Dexamethasone/IBMX/Insulin) and rosiglitazone induced adipocyte differentiation [<xref rid="r46" ref-type="bibr">Chawla and Lazar, 1993</xref>; <xref rid="r118" ref-type="bibr">Fu et al., 2005</xref>; <xref rid="r90" ref-type="bibr">Laitinen et al., 2005</xref>]. Rosiglitazone induced adipogenesis involves PPAR-&#x003b3; mediated induction of Rev-erb&#x003b1; mRNA expression. In agreement, exogenous expression of Rev-erb&#x003b1; in 3T3-L1 cells promoted adipogenic differentiation [<xref rid="r122" ref-type="bibr">Fontaine et al., 2003</xref>]. In contrast, Rev-erb&#x003b1; and &#x003b2; antagonistically regulate mammalian muscle differentiation and their expression levels decrease during myogenesis [<xref rid="r7" ref-type="bibr">Burke et al., 1996</xref>; <xref rid="r55" ref-type="bibr">Downes et al., 1995</xref>].</p><p><italic>In vivo</italic> studies in mice suggest that Rev-erb&#x003b1; is preferentially expressed in fast-twitch type IIB and intermediate typeIIA fibers. Moreover, in slow twitch (type I) soleus muscle of Rev-erb&#x003b1; homozygous and heterozygous null mutant mice, there is a significant increase in the expression of the &#x003b2;/slow myosin heavy chain (MyHC) isoform [<xref rid="r116" ref-type="bibr">Pircher et al., 2005</xref>]. Type IIB fast fibers utilize glycolysis, in contrast, type IIA combine fast twitch glycolytic capacity with aerobic metabolism. Type I fibers are dependent on the aerobic metabolism of fatty acids. The expression of Rev-erb&#x003b1; in energy demanding tissues, the fiber specific expression characteristics, and the effect of the null mutation on the muscle phenotype suggest a role in metabolism.</p><p>In this context, it has been shown that ectopic Rev-erb&#x003b2;&#x00394;E (that lacks the LBD) expression in skeletal muscle cells attenuated the expression of many genes involved in fatty acid/lipid absorption (including FAT/CD36, FABP-3 and -4), and an expected increase in ROR&#x003b1; expression [<xref rid="r40" ref-type="bibr">Ramakrishnan et al., 2005</xref>]. Interestingly, these authors reported a dramatic decrease in the expression of the mRNA encoding myostatin, a TGF-&#x003b2; family member that plays a crucial role in regulating muscle and adipose mass [<xref rid="r114" ref-type="bibr">Gonzalez-Cadavid and Bhasin, 2004</xref>]. Myostatin -/- mice have increased skeletal muscle mass (from muscle hypertrophy and hyperplasia) accompanied by decreased adiposity. McPherron and Lee reported that the introduction of the myostatin mutation in mouse models of obesity and diabetes, suppressed fat accumulation and hyperglycemia [<xref rid="r34" ref-type="bibr">McPherron and Lee, 2002</xref>]. The Rev-erb&#x003b1; and Rev-erb&#x003b2; target genes and tissues are schematically depicted in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</p></sec><sec><title>Rev-erbs and circadian rhythm</title><p>Rev-erb&#x003b1; is involved in circadian timing in brain and liver tissue, and regulates BMAL1, and to a lesser extent CLOCK expression (see <xref ref-type="fig" rid="fig2">Figure 2</xref>) [<xref rid="r103" ref-type="bibr">Balsalobre et al., 1998</xref>; <xref rid="r102" ref-type="bibr">Torra et al., 2000</xref>]. Rev-Erb&#x003b1; itself is driven directly by the molecular oscillator, it is activated by the BMAL1-CLOCK heterodimer, and repressed by PERIOD1/2 and CRYPTOCHROME1/2 proteins [<xref rid="r87" ref-type="bibr">Preitner et al., 2002</xref>; <xref rid="r65" ref-type="bibr">Triqueneaux et al., 2004</xref>]. It is interesting to note that Rev-erb&#x003b1; and ROR&#x003b1; opposingly regulate Bmal1 expression and are an integral component of a complex transcriptional feedback loop (see <xref ref-type="fig" rid="fig2">Figure 2</xref>) [<xref rid="r103" ref-type="bibr">Balsalobre et al., 1998</xref>; <xref rid="r93" ref-type="bibr">Emery and Reppert, 2004</xref>; <xref rid="r91" ref-type="bibr">Sato et al., 2004</xref>; <xref rid="r102" ref-type="bibr">Torra et al., 2000</xref>]. The amplitude of Bmal1, Clock, and Cry1 mRNA oscillations are significantly attenuated in Rev-erb&#x003b1; -/- mice. Rev-erb&#x003b1; has been shown to influence period length and phase shifting. Schibler and colleagues demonstrated that Rev-erb&#x003b1; -/- mice kept under constant darkness and constant light conditions had a shorter period length compared to wild-type animals [<xref rid="r87" ref-type="bibr">Preitner et al., 2002</xref>]. Curiously, the maintenance of circadian pacemaker by Rev-erb&#x003b1; is also conserved in other organisms such as zebrafish [<xref rid="r101" ref-type="bibr">Delaunay et al., 2000</xref>]. Laudet and colleagues have hypothesized that Rev-erb&#x003b1; can function as integrator of circadian and physiological events [<xref rid="r65" ref-type="bibr">Triqueneaux et al., 2004</xref>]. The literature provides copious examples of circadian regulation of blood pressure, and hypertensive fluctuations associated with cardiovascular disease [<xref rid="r86" ref-type="bibr">Giles, 2005</xref>; <xref rid="r85" ref-type="bibr">Ikeda et al., 2004</xref>]. Furthermore, aberrant sleep cycles in humans lead to increased secretion of proinflammatory cytokines (for example TNF&#x003b1; and IL-6) [<xref rid="r73" ref-type="bibr">Vgontzas et al., 2004</xref>] and reduced cortisol secretion [<xref rid="r74" ref-type="bibr">Takahashi et al., 2001</xref>]. In this context, mice treated with prednisolone repressed Rev-erb&#x003b1; and Bmal1 expression [<xref rid="r121" ref-type="bibr">Koyanagi et al., 2006</xref>]. Very recently, Yin et al. demonstrated that glycogen synthase kinase 3 (GSK3)-mediated phosphorylation of Rev-erb&#x003b1; and stabilizes the expression of the nuclear receptor [<xref rid="r120" ref-type="bibr">Yin et al., 2006</xref>]. Excitingly, they went on to demonstrate that lithium treatment (commonly used to treat bipolar disorder) leads to proteosomal degradation of Rev-erb&#x003b1; and induction of Bmal 1. This process is mediated by lithium induced inhibition of GSK3. Finally, a report from Cermakian and colleagues also highlights that Rev-erb&#x003b2; can regulate circadian transcription of the Bmal1 gene [<xref rid="r113" ref-type="bibr">Guillaumond et al., 2005</xref>].</p></sec><sec><title>Rev-erbs and inflammation</title><p>Lipopolysaccharide induced activation of bone marrow derived macrophages induces biphasic regulation of Rev-erb&#x003b2; [<xref rid="r115" ref-type="bibr">Barish et al., 2005</xref>]. Recent studies have shown that inflammatory cytokines play crucial roles in endothelial and smooth muscle cell responses in diseases associated with the vasculature. Vascular smooth muscle cells over-expressing Rev-erb&#x003b1; induced NF-&#x003ba;B mediated trans-activation (and p65 translocation). In addition, increased expression of the pro-inflammatory cytokines IL-6 and COX-2 was observed [<xref rid="r60" ref-type="bibr">Migita et al., 2004</xref>]. Concordantly, ectopic expression of ROR&#x003b1;in human smooth muscle cells inhibits TNF&#x003b1; mediated induction of IL-6, IL-8, and COX-2 expression through induction of I&#x003ba;B&#x003b1; [<xref rid="r117" ref-type="bibr">Delerive et al., 2001</xref>]. The attenuation of Rev-erb&#x003b2; expression/function in skeletal muscle cells has been reported to induce IL-6 mRNA expression. Paradoxically, this was associated with increased expression of ROR&#x003b1; and I&#x003ba;B&#x003b1;[<xref rid="r40" ref-type="bibr">Ramakrishnan et al., 2005</xref>]. IL-6 is an exercise induced myokine that induces lipolysis in adipose tissue, and suppresses TNF&#x003b1; production. The increased expression of IL-6 is consistent with decreased myostatin expression. For example, it has been reported that IL-6 deficiency leads to late-onset obesity [<xref rid="r79" ref-type="bibr">Wallenius et al., 2002</xref>], whereas myostatin deficiency leads to the reduced accumulation of body fat [<xref rid="r34" ref-type="bibr">McPherron and Lee, 2002</xref>]. Therefore, the inverse correlation between IL-6 and myostatin expression after attenuation of Rev-erb&#x003b2; expression is in concordance with the reported phenotypic effects of these proteins. The studies above highlight the emerging role of Rev-erbs in the inflammation cascade.</p></sec><sec><title>Concluding remarks and future directions</title><p>Molecular modeling suggests the cavities in the LBDs of the NR1D subgroup are occupied by bulky side chains. This indicates that pharmacological manipulation of this orphan NR subgroup by agonists and antagonists in the near future may present technical challenges. However, a recent report from Reinking et al [<xref rid="r107" ref-type="bibr">Reinking et al., 2005</xref>] has shown that the ligand binding pocket of E75, a Drosophila orthologue of human Rev-erb&#x003b1; is tightly bound by heme. In recent years, various heme containing molecules have been identified to regulate lipid homeostasis. For example, heme containing neuronal nitric oxide synthase regulates genes involved in the lipogenesis pathway [<xref rid="r119" ref-type="bibr">Schild et al., 2006</xref>]. Curiously, Reinking and colleagues also identified E75 as a potential gas sensor and that CO or NO bind to E75 to interfere with E75 mediated repression of DHR3, a Drosophila orthologue of human ROR&#x003b1;, see <xref ref-type="fig" rid="fig3">Figure 3</xref>). Moreover, heme, NO and CO are important regulatory molecules in mammalian circadian clocks (reviewed in [<xref rid="r110" ref-type="bibr">Pardee et al., 2004</xref>]). Recently, cholesterol/cholesterol sulphate and all-trans retinoic acid have been identified as ROR&#x003b1; and ROR&#x003b2; agonists, respectively [<xref rid="r105" ref-type="bibr">Kallen et al., 2004</xref>; <xref rid="r106" ref-type="bibr">Kallen et al., 2002</xref>; <xref rid="r104" ref-type="bibr">Stehlin-Gaon et al., 2003</xref>]. In summary, these studies suggest that identification of novel synthetic small molecule regulators for the NR1D subgroup by contemporary chemistry in the near future is possible.</p><p>Further insights into the function of the NR1D subgroup in the short term will require targeted genetic analysis of both Rev-erb&#x003b1; and &#x003b2; in specific tissues and organs. Cell specific attenuation of the NR1D subgroup (by Cre-Lox and/or transgenic techniques) in the major mass tissues (including skeletal muscle, liver and adipose tissue) will provide novel insights into the physiological role of these orphan NRs in metabolism.</p><p>The NR1D subgroups are transcriptional silencers, and identification of target genes is certainly an area requiring additional study. Current studies indicate Rev-erb signaling impacts on ROR&#x003b1; and PPAR&#x003b1;-mediated control of inflammation and metabolism. Furthermore, it is increasingly apparent that Rev-erb&#x003b1; is an integral component of complex transcriptional feedback loops that are involved in circadian control. Complete elucidation of the pathophysiologically relevant targets of the Rev-erbs and the crosstalk with other NR signaling pathways in a cell/organ specific context will provide unique insights into the links between metabolism, inflammation and the circadian cycle in homeostasis.</p></sec></body><back><ack><p>We apologize to those authors whose work was not cited in the pursuit of brevity. We thank Michael Pearen for his help in preparing Figure 1. SR holds an University of Queensland Postgraduate Scholarship. GEOM is a Principal Research Fellow of the National Health and Medical Research Council of Australia (NHMRC), and this study was supported by an NHMRC project grant. </p></ack><glossary><title>Abbreviations</title><def-list><def-item><term>apoA1</term><def><p> apolipoprotein A1</p></def></def-item><def-item><term>apoCIII</term><def><p> apolipoprotein CIII</p></def></def-item><def-item><term>apoE</term><def><p> apolipoprotein E</p></def></def-item><def-item><term>BMAL1</term><def><p> Brain and Muscle Arnt-like protein-1 </p></def></def-item><def-item><term>bp</term><def><p> base pair(s)</p></def></def-item><def-item><term>CO</term><def><p> carbon-monoxide</p></def></def-item><def-item><term>COX-2</term><def><p> cyclooxygenase 2</p></def></def-item><def-item><term>DR2</term><def><p> direct repeat 2</p></def></def-item><def-item><term>FABP</term><def><p> fatty acid binding protein</p></def></def-item><def-item><term>FAT/CD36</term><def><p> fatty acid translocase</p></def></def-item><def-item><term>HDL</term><def><p> high density lipoprotein</p></def></def-item><def-item><term>IL-6</term><def><p> Interleukin-6</p></def></def-item><def-item><term>I&#x003ba;B&#x003b1;</term><def><p> Inhibitor of NF;</p></def></def-item><def-item><term>LBD</term><def><p> ligand binding domain</p></def></def-item><def-item><term>NF&#x003ba;B</term><def><p> nuclear factor &#x003ba;B</p></def></def-item><def-item><term>NO</term><def><p> nitric-oxide</p></def></def-item><def-item><term>NR</term><def><p> nuclear receptor</p></def></def-item><def-item><term>PPAR</term><def><p> peroxisome proliferators-activated receptor</p></def></def-item><def-item><term>ROR</term><def><p> RAR-related orphan receptor</p></def></def-item><def-item><term>TGF-&#x003b2;</term><def><p> transforming growth factor &#x003b2;</p></def></def-item><def-item><term>TNF-&#x003b1;</term><def><p> tumor necrosis factor &#x003b1;</p></def></def-item><def-item><term>VLDL</term><def><p> very low density lipoprotein</p></def></def-item></def-list></glossary><ref-list><ref id="r5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adelmant</surname><given-names>G.</given-names></name><name><surname>Begue</surname><given-names>A.</given-names></name><name><surname>Stehelin</surname><given-names>D.</given-names></name><name><surname>Laudet</surname><given-names>V.</given-names></name></person-group><article-title>A functional Rev-erb &#x003b1; responsive element located in the human Rev-erb &#x003b1; promoter mediates a repressing activity</article-title><source>Proc Natl Acad Sci U S A</source><year>1996</year><volume>93</volume><fpage>3553</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">8622974</pub-id></citation></ref><ref id="r103"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Balsalobre</surname><given-names>A.</given-names></name><name><surname>Damiola</surname><given-names>F.</given-names></name><name><surname>Schibler</surname><given-names>U.</given-names></name></person-group><article-title>A serum shock induces circadian gene expression in mammalian tissue culture cells</article-title><source>Cell</source><year>1998</year><volume>93</volume><fpage>929</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">9635423</pub-id></citation></ref><ref id="r115"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barish</surname><given-names>G. D.</given-names></name><name><surname>Downes</surname><given-names>M.</given-names></name><name><surname>Alaynick</surname><given-names>W. A.</given-names></name><name><surname>Yu</surname><given-names>R. T.</given-names></name><name><surname>Ocampo</surname><given-names>C. B.</given-names></name><name><surname>Bookout</surname><given-names>A. L.</given-names></name><name><surname>Mangelsdorf</surname><given-names>D. J.</given-names></name><name><surname>Evans</surname><given-names>R. M.</given-names></name></person-group><article-title>A Nuclear Receptor Atlas: macrophage activation</article-title><source>Mol Endocrinol</source><year>2005</year><volume>19</volume><fpage>2466</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">16051664</pub-id></citation></ref><ref id="r7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burke</surname><given-names>L.</given-names></name><name><surname>Downes</surname><given-names>M.</given-names></name><name><surname>Carozzi</surname><given-names>A.</given-names></name><name><surname>Giguere</surname><given-names>V.</given-names></name><name><surname>Muscat</surname><given-names>G. E.</given-names></name></person-group><article-title>Transcriptional repression by the orphan steroid receptor RVR/Rev-erb &#x003b2; is dependent on the signature motif and helix 5 in the E region: functional evidence for a biological role of RVR in myogenesis</article-title><source>Nucleic Acids Res</source><year>1996</year><volume>24</volume><fpage>3481</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">8836172</pub-id></citation></ref><ref id="r46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chawla</surname><given-names>A.</given-names></name><name><surname>Lazar</surname><given-names>M. A.</given-names></name></person-group><article-title>Induction of Rev-ErbA &#x003b1;, an orphan receptor encoded on the opposite strand of the &#x003b1;-thyroid hormone receptor gene, during adipocyte differentiation</article-title><source>J Biol Chem</source><year>1993</year><volume>268</volume><fpage>16265</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">8344913</pub-id></citation></ref><ref id="r100"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chomez</surname><given-names>P.</given-names></name><name><surname>Neveu</surname><given-names>I.</given-names></name><name><surname>Mansen</surname><given-names>A.</given-names></name><name><surname>Kiesler</surname><given-names>E.</given-names></name><name><surname>Larsson</surname><given-names>L.</given-names></name><name><surname>Vennstrom</surname><given-names>B.</given-names></name><name><surname>Arenas</surname><given-names>E.</given-names></name></person-group><article-title>Increased cell death and delayed development in the cerebellum of mice lacking the rev-erbA(&#x003b1;) orphan receptor</article-title><source>Development</source><year>2000</year><volume>127</volume><fpage>1489</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">10704394</pub-id></citation></ref><ref id="r12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coste</surname><given-names>H.</given-names></name><name><surname>Rodriguez</surname><given-names>J. C.</given-names></name></person-group><article-title>Orphan nuclear hormone receptor Rev-erbalpha regulates the human apolipoprotein CIII promoter</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>27120</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">12021280</pub-id></citation></ref><ref id="r101"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Delaunay</surname><given-names>F.</given-names></name><name><surname>Thisse</surname><given-names>C.</given-names></name><name><surname>Marchand</surname><given-names>O.</given-names></name><name><surname>Laudet</surname><given-names>V.</given-names></name><name><surname>Thisse</surname><given-names>B.</given-names></name></person-group><article-title>An inherited functional circadian clock in zebrafish embryos</article-title><source>Science</source><year>2000</year><volume>289</volume><fpage>297</fpage><lpage>300</lpage><pub-id pub-id-type="pmid">10894777</pub-id></citation></ref><ref id="r76"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Delerive</surname><given-names>P.</given-names></name><name><surname>Chin</surname><given-names>W. W.</given-names></name><name><surname>Suen</surname><given-names>C. S.</given-names></name></person-group><article-title>Identification of Reverb(&#x003b1;) as a novel ROR(&#x003b1;) target gene</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>35013</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">12114512</pub-id></citation></ref><ref id="r117"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Delerive</surname><given-names>P.</given-names></name><name><surname>Monte</surname><given-names>D.</given-names></name><name><surname>Dubois</surname><given-names>G.</given-names></name><name><surname>Trottein</surname><given-names>F.</given-names></name><name><surname>Fruchart-Najib</surname><given-names>J.</given-names></name><name><surname>Mariani</surname><given-names>J.</given-names></name><name><surname>Fruchart</surname><given-names>J. C.</given-names></name><name><surname>Staels</surname><given-names>B.</given-names></name></person-group><article-title>The orphan nuclear receptor ROR &#x003b1; is a negative regulator of the inflammatory response</article-title><source>EMBO Rep</source><year>2001</year><volume>2</volume><fpage>42</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11252722</pub-id></citation></ref><ref id="r55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Downes</surname><given-names>M.</given-names></name><name><surname>Carozzi</surname><given-names>A. J.</given-names></name><name><surname>Muscat</surname><given-names>G. E.</given-names></name></person-group><article-title>Constitutive expression of the orphan receptor, Rev-erbA &#x003b1;, inhibits muscle differentiation and abrogates the expression of the myoD gene family</article-title><source>Mol Endocrinol</source><year>1995</year><volume>9</volume><fpage>1666</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">8614403</pub-id></citation></ref><ref id="r83"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dumas</surname><given-names>B.</given-names></name><name><surname>Harding</surname><given-names>H. P.</given-names></name><name><surname>Choi</surname><given-names>H. S.</given-names></name><name><surname>Lehmann</surname><given-names>K. A.</given-names></name><name><surname>Chung</surname><given-names>M.</given-names></name><name><surname>Lazar</surname><given-names>M. A.</given-names></name><name><surname>Moore</surname><given-names>D. D.</given-names></name></person-group><article-title>A new orphan member of the nuclear hormone receptor superfamily closely related to Rev-Erb</article-title><source>Mol Endocrinol</source><year>1994</year><volume>8</volume><fpage>996</fpage><lpage>1005</lpage><pub-id pub-id-type="pmid">7997240</pub-id></citation></ref><ref id="r93"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Emery</surname><given-names>P.</given-names></name><name><surname>Reppert</surname><given-names>S. M.</given-names></name></person-group><article-title>A rhythmic Ror</article-title><source>Neuron</source><year>2004</year><volume>43</volume><fpage>443</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">15312644</pub-id></citation></ref><ref id="r122"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fontaine</surname><given-names>C.</given-names></name><name><surname>Dubois</surname><given-names>G.</given-names></name><name><surname>Duguay</surname><given-names>Y.</given-names></name><name><surname>Helledie</surname><given-names>T.</given-names></name><name><surname>Vu-Dac</surname><given-names>N.</given-names></name><name><surname>Gervois</surname><given-names>P.</given-names></name><name><surname>Soncin</surname><given-names>F.</given-names></name><name><surname>Mandrup</surname><given-names>S.</given-names></name><name><surname>Fruchart</surname><given-names>J. C.</given-names></name><name><surname>Fruchart-Najib</surname><given-names>J.</given-names></name><name><surname>Staels</surname><given-names>B.</given-names></name></person-group><article-title>The orphan nuclear receptor Rev-Erbalpha is a peroxisome proliferator-activated receptor (PPAR) &#x003b3; target gene and promotes PPARgamma-induced adipocyte differentiation</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>37672</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">12821652</pub-id></citation></ref><ref id="r4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Forman</surname><given-names>B. M.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Blumberg</surname><given-names>B.</given-names></name><name><surname>Kliewer</surname><given-names>S. A.</given-names></name><name><surname>Henshaw</surname><given-names>R.</given-names></name><name><surname>Ong</surname><given-names>E. S.</given-names></name><name><surname>Evans</surname><given-names>R. M.</given-names></name></person-group><article-title>Cross-talk among ROR &#x003b1; 1 and the Rev-erb family of orphan nuclear receptors</article-title><source>Mol Endocrinol</source><year>1994</year><volume>8</volume><fpage>1253</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">7838158</pub-id></citation></ref><ref id="r118"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>M.</given-names></name><name><surname>Sun</surname><given-names>T.</given-names></name><name><surname>Bookout</surname><given-names>A. L.</given-names></name><name><surname>Downes</surname><given-names>M.</given-names></name><name><surname>Yu</surname><given-names>R. T.</given-names></name><name><surname>Evans</surname><given-names>R. M.</given-names></name><name><surname>Mangelsdorf</surname><given-names>D. J.</given-names></name></person-group><article-title>A Nuclear Receptor Atlas: 3T3-L1 adipogenesis</article-title><source>Mol Endocrinol</source><year>2005</year><volume>19</volume><fpage>2437</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">16051663</pub-id></citation></ref><ref id="r96"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gervois</surname><given-names>P.</given-names></name><name><surname>Chopin-Delannoy</surname><given-names>S.</given-names></name><name><surname>Fadel</surname><given-names>A.</given-names></name><name><surname>Dubois</surname><given-names>G.</given-names></name><name><surname>Kosykh</surname><given-names>V.</given-names></name><name><surname>Fruchart</surname><given-names>J. C.</given-names></name><name><surname>Najib</surname><given-names>J.</given-names></name><name><surname>Laudet</surname><given-names>V.</given-names></name><name><surname>Staels</surname><given-names>B.</given-names></name></person-group><article-title>Fibrates increase human REV-ERBalpha expression in liver via a novel peroxisome proliferator-activated receptor response element</article-title><source>Mol Endocrinol</source><year>1999</year><volume>13</volume><fpage>400</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">10076997</pub-id></citation></ref><ref id="r84"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Giguere</surname><given-names>V.</given-names></name><name><surname>Tini</surname><given-names>M.</given-names></name><name><surname>Flock</surname><given-names>G.</given-names></name><name><surname>Ong</surname><given-names>E.</given-names></name><name><surname>Evans</surname><given-names>R. M.</given-names></name><name><surname>Otulakowski</surname><given-names>G.</given-names></name></person-group><article-title>Isoform-specific amino-terminal domains dictate DNA-binding properties of ROR &#x003b1;, a novel family of orphan hormone nuclear receptors</article-title><source>Genes Dev</source><year>1994</year><volume>8</volume><fpage>538</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">7926749</pub-id></citation></ref><ref id="r86"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Giles</surname><given-names>T.</given-names></name></person-group><article-title>Relevance of blood pressure variation in the circadian onset of cardiovascular events</article-title><source>J Hypertens</source><year>2005</year><volume>23 Suppl 1</volume><fpage>S35</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15821450</pub-id></citation></ref><ref id="r114"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Cadavid</surname><given-names>N. F.</given-names></name><name><surname>Bhasin</surname><given-names>S.</given-names></name></person-group><article-title>Role of myostatin in metabolism</article-title><source>Curr Opin Clin Nutr Metab Care</source><year>2004</year><volume>7</volume><fpage>451</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15192449</pub-id></citation></ref><ref id="r70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gronemeyer</surname><given-names>H.</given-names></name><name><surname>Gustafsson</surname><given-names>J. A.</given-names></name><name><surname>Laudet</surname><given-names>V.</given-names></name></person-group><article-title>Principles for modulation of the nuclear receptor superfamily</article-title><source>Nat Rev Drug Discov</source><year>2004</year><volume>3</volume><fpage>950</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">15520817</pub-id></citation></ref><ref id="r113"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guillaumond</surname><given-names>F.</given-names></name><name><surname>Dardente</surname><given-names>H.</given-names></name><name><surname>Giguere</surname><given-names>V.</given-names></name><name><surname>Cermakian</surname><given-names>N.</given-names></name></person-group><article-title>Differential control of Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors</article-title><source>J Biol Rhythms</source><year>2005</year><volume>20</volume><fpage>391</fpage><lpage>403</lpage><pub-id pub-id-type="pmid">16267379</pub-id></citation></ref><ref id="r85"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>T.</given-names></name><name><surname>Gomi</surname><given-names>T.</given-names></name><name><surname>Shibuya</surname><given-names>Y.</given-names></name><name><surname>Matsuo</surname><given-names>K.</given-names></name><name><surname>Kosugi</surname><given-names>T.</given-names></name><name><surname>Oku</surname><given-names>N.</given-names></name><name><surname>Uetake</surname><given-names>Y.</given-names></name><name><surname>Kinugasa</surname><given-names>S.</given-names></name><name><surname>Furutera</surname><given-names>R.</given-names></name></person-group><article-title>Morning rise in blood pressure is a predictor of left ventricular hypertrophy in treated hypertensive patients</article-title><source>Hypertens Res</source><year>2004</year><volume>27</volume><fpage>939</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">15894834</pub-id></citation></ref><ref id="r105"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kallen</surname><given-names>J.</given-names></name><name><surname>Schlaeppi</surname><given-names>J. M.</given-names></name><name><surname>Bitsch</surname><given-names>F.</given-names></name><name><surname>Delhon</surname><given-names>I.</given-names></name><name><surname>Fournier</surname><given-names>B.</given-names></name></person-group><article-title>Crystal structure of the human RORalpha Ligand binding domain in complex with cholesterol sulfate at 2.2 A</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>14033</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">14722075</pub-id></citation></ref><ref id="r106"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kallen</surname><given-names>J. A.</given-names></name><name><surname>Schlaeppi</surname><given-names>J. M.</given-names></name><name><surname>Bitsch</surname><given-names>F.</given-names></name><name><surname>Geisse</surname><given-names>S.</given-names></name><name><surname>Geiser</surname><given-names>M.</given-names></name><name><surname>Delhon</surname><given-names>I.</given-names></name><name><surname>Fournier</surname><given-names>B.</given-names></name></person-group><article-title>X-ray structure of the hRORalpha LBD at 1.63 A: structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORalpha</article-title><source>Structure (Camb)</source><year>2002</year><volume>10</volume><fpage>1697</fpage><lpage>707</lpage><pub-id pub-id-type="pmid">12467577</pub-id></citation></ref><ref id="r109"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kassam</surname><given-names>A.</given-names></name><name><surname>Capone</surname><given-names>J. P.</given-names></name><name><surname>Rachubinski</surname><given-names>R. A.</given-names></name></person-group><article-title>Orphan nuclear hormone receptor RevErbalpha modulates expression from the promoter of the hydratase-dehydrogenase gene by inhibiting peroxisome proliferator-activated receptor &#x003b1;-dependent transactivation</article-title><source>J Biol Chem</source><year>1999</year><volume>274</volume><fpage>22895</fpage><lpage>900</lpage><pub-id pub-id-type="pmid">10428876</pub-id></citation></ref><ref id="r121"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koyanagi</surname><given-names>S.</given-names></name><name><surname>Okazawa</surname><given-names>S.</given-names></name><name><surname>Kuramoto</surname><given-names>Y.</given-names></name><name><surname>Ushijima</surname><given-names>K.</given-names></name><name><surname>Shimeno</surname><given-names>H.</given-names></name><name><surname>Soeda</surname><given-names>S.</given-names></name><name><surname>Okamura</surname><given-names>H.</given-names></name><name><surname>Ohdo</surname><given-names>S.</given-names></name></person-group><article-title>Chronic treatment with prednisolone represses the circadian oscillation of clock gene expression in mouse peripheral tissues</article-title><source>Mol Endocrinol</source><year>2006</year><volume>20</volume><fpage>573</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">16269518</pub-id></citation></ref><ref id="r47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laitinen</surname><given-names>S.</given-names></name><name><surname>Staels</surname><given-names>B.</given-names></name></person-group><article-title/><source>Nucl Recept Signal</source><year>2003</year><volume>4</volume></citation></ref><ref id="r90"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laitinen</surname><given-names>S.</given-names></name><name><surname>Fontaine</surname><given-names>C.</given-names></name><name><surname>Fruchart</surname><given-names>J. C.</given-names></name><name><surname>Staels</surname><given-names>B.</given-names></name></person-group><article-title>The role of the orphan nuclear receptor Rev-Erb &#x003b1; in adipocyte differentiation and function</article-title><source>Biochimie</source><year>2005</year><volume>87</volume><fpage>21</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">15733732</pub-id></citation></ref><ref id="r81"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lazar</surname><given-names>M. A.</given-names></name><name><surname>Hodin</surname><given-names>R. A.</given-names></name><name><surname>Darling</surname><given-names>D. S.</given-names></name><name><surname>Chin</surname><given-names>W. W.</given-names></name></person-group><article-title>A novel member of the thyroid/steroid hormone receptor family is encoded by the opposite strand of the rat c-erbA &#x003b1; transcriptional unit</article-title><source>Mol Cell Biol</source><year>1989</year><volume>9</volume><fpage>1128</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">2542765</pub-id></citation></ref><ref id="r34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McPherron</surname><given-names>A. C.</given-names></name><name><surname>Lee</surname><given-names>S. J.</given-names></name></person-group><article-title>Suppression of body fat accumulation in myostatin-deficient mice</article-title><source>J Clin Invest</source><year>2002</year><volume>109</volume><fpage>595</fpage><lpage>601</lpage><pub-id pub-id-type="pmid">11877467</pub-id></citation></ref><ref id="r60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Migita</surname><given-names>H.</given-names></name><name><surname>Morser</surname><given-names>J.</given-names></name><name><surname>Kawai</surname><given-names>K.</given-names></name></person-group><article-title>Rev-erbalpha upregulates NF-kappaB-responsive genes in vascular smooth muscle cells</article-title><source>FEBS Lett</source><year>2004</year><volume>561</volume><fpage>69</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">15013753</pub-id></citation></ref><ref id="r110"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pardee</surname><given-names>K.</given-names></name><name><surname>Reinking</surname><given-names>J.</given-names></name><name><surname>Krause</surname><given-names>H.</given-names></name></person-group><article-title>Nuclear hormone receptors, metabolism, and aging: what goes around comes around.Transcription factors link lipid metabolism and aging-related processes</article-title><source>Sci Aging Knowledge Environ</source><year>2004</year><volume>2004</volume><pub-id pub-id-type="pmid">15564562</pub-id></citation></ref><ref id="r116"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pircher</surname><given-names>P.</given-names></name><name><surname>Chomez</surname><given-names>P.</given-names></name><name><surname>Yu</surname><given-names>F.</given-names></name><name><surname>Vennstrom</surname><given-names>B.</given-names></name><name><surname>Larsson</surname><given-names>L.</given-names></name></person-group><article-title>Aberrant expression of myosin isoforms in skeletal muscles from mice lacking the rev-erbAalpha orphan receptor gene</article-title><source>Am J Physiol Regul Integr Comp Physiol</source><year>2005</year><volume>288</volume><fpage>R482</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">15374821</pub-id></citation></ref><ref id="r87"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Preitner</surname><given-names>N.</given-names></name><name><surname>Damiola</surname><given-names>F.</given-names></name><name><surname>Lopez-Molina</surname><given-names>L.</given-names></name><name><surname>Zakany</surname><given-names>J.</given-names></name><name><surname>Duboule</surname><given-names>D.</given-names></name><name><surname>Albrecht</surname><given-names>U.</given-names></name><name><surname>Schibler</surname><given-names>U.</given-names></name></person-group><article-title>The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator</article-title><source>Cell</source><year>2002</year><volume>110</volume><fpage>251</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">12150932</pub-id></citation></ref><ref id="r40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ramakrishnan</surname><given-names>S. N.</given-names></name><name><surname>Lau</surname><given-names>P.</given-names></name><name><surname>Burke</surname><given-names>L. J.</given-names></name><name><surname>Muscat</surname><given-names>G. E.</given-names></name></person-group><article-title>Rev-erbbeta regulates the expression of genes involved in lipid absorption in skeletal muscle cells: evidence for cross-talk between orphan nuclear receptors and myokines</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><fpage>8651</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15623503</pub-id></citation></ref><ref id="r13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Raspe</surname><given-names>E.</given-names></name><name><surname>Duez</surname><given-names>H.</given-names></name><name><surname>Mansen</surname><given-names>A.</given-names></name><name><surname>Fontaine</surname><given-names>C.</given-names></name><name><surname>Fievet</surname><given-names>C.</given-names></name><name><surname>Fruchart</surname><given-names>J. C.</given-names></name><name><surname>Vennstrom</surname><given-names>B.</given-names></name><name><surname>Staels</surname><given-names>B.</given-names></name></person-group><article-title>Identification of Rev-erbalpha as a physiological repressor of apoC-III gene transcription</article-title><source>J Lipid Res</source><year>2002b</year><volume>43</volume><fpage>2172</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">12454280</pub-id></citation></ref><ref id="r99"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Raspe</surname><given-names>E.</given-names></name><name><surname>Mautino</surname><given-names>G.</given-names></name><name><surname>Duval</surname><given-names>C.</given-names></name><name><surname>Fontaine</surname><given-names>C.</given-names></name><name><surname>Duez</surname><given-names>H.</given-names></name><name><surname>Barbier</surname><given-names>O.</given-names></name><name><surname>Monte</surname><given-names>D.</given-names></name><name><surname>Fruchart</surname><given-names>J.</given-names></name><name><surname>Fruchart</surname><given-names>J. C.</given-names></name><name><surname>Staels</surname><given-names>B.</given-names></name></person-group><article-title>Transcriptional regulation of human Rev-erbalpha gene expression by the orphan nuclear receptor retinoic acid-related orphan receptor &#x003b1;</article-title><source>J Biol Chem</source><year>2002a</year><volume>277</volume><fpage>49275</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">12377782</pub-id></citation></ref><ref id="r107"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reinking</surname><given-names>J.</given-names></name><name><surname>Lam</surname><given-names>M. M.</given-names></name><name><surname>Pardee</surname><given-names>K.</given-names></name><name><surname>Sampson</surname><given-names>H. M.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>P.</given-names></name><name><surname>Williams</surname><given-names>S.</given-names></name><name><surname>White</surname><given-names>W.</given-names></name><name><surname>Lajoie</surname><given-names>G.</given-names></name><name><surname>Edwards</surname><given-names>A.</given-names></name><name><surname>Krause</surname><given-names>H. M.</given-names></name></person-group><article-title>The Drosophila nuclear receptor e75 contains heme and is gas responsive</article-title><source>Cell</source><year>2005</year><volume>122</volume><fpage>195</fpage><lpage>207</lpage><pub-id pub-id-type="pmid">16051145</pub-id></citation></ref><ref id="r77"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Renaud</surname><given-names>J. P.</given-names></name><name><surname>Harris</surname><given-names>J. M.</given-names></name><name><surname>Downes</surname><given-names>M.</given-names></name><name><surname>Burke</surname><given-names>L. J.</given-names></name><name><surname>Muscat</surname><given-names>G. E.</given-names></name></person-group><article-title>Structure-function analysis of the Rev-erbA and RVR ligand-binding domains reveals a large hydrophobic surface that mediates corepressor binding and a ligand cavity occupied by side chains</article-title><source>Mol Endocrinol</source><year>2000</year><volume>14</volume><fpage>700</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">10809233</pub-id></citation></ref><ref id="r82"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Retnakaran</surname><given-names>R.</given-names></name><name><surname>Flock</surname><given-names>G.</given-names></name><name><surname>Giguere</surname><given-names>V.</given-names></name></person-group><article-title>Identification of RVR, a novel orphan nuclear receptor that acts as a negative transcriptional regulator</article-title><source>Mol Endocrinol</source><year>1994</year><volume>8</volume><fpage>1234</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">7838156</pub-id></citation></ref><ref id="r91"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>T. K.</given-names></name><name><surname>Panda</surname><given-names>S.</given-names></name><name><surname>Miraglia</surname><given-names>L. J.</given-names></name><name><surname>Reyes</surname><given-names>T. M.</given-names></name><name><surname>Rudic</surname><given-names>R. D.</given-names></name><name><surname>McNamara</surname><given-names>P.</given-names></name><name><surname>Naik</surname><given-names>K. A.</given-names></name><name><surname>FitzGerald</surname><given-names>G. A.</given-names></name><name><surname>Kay</surname><given-names>S. A.</given-names></name><name><surname>Hogenesch</surname><given-names>J. B.</given-names></name></person-group><article-title>A functional genomics strategy reveals Rora as a component of the mammalian circadian clock</article-title><source>Neuron</source><year>2004</year><volume>43</volume><fpage>527</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">15312651</pub-id></citation></ref><ref id="r119"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schild</surname><given-names>L.</given-names></name><name><surname>Jaroscakova</surname><given-names>I.</given-names></name><name><surname>Lendeckel</surname><given-names>U.</given-names></name><name><surname>Wolf</surname><given-names>G.</given-names></name><name><surname>Keilhoff</surname><given-names>G.</given-names></name></person-group><article-title>Neuronal nitric oxide synthase controls enzyme activity pattern of mitochondria and lipid metabolism</article-title><source>Faseb J</source><year>2006</year><volume>20</volume><fpage>145</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">16246868</pub-id></citation></ref><ref id="r104"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stehlin-Gaon</surname><given-names>C.</given-names></name><name><surname>Willmann</surname><given-names>D.</given-names></name><name><surname>Zeyer</surname><given-names>D.</given-names></name><name><surname>Sanglier</surname><given-names>S.</given-names></name><name><surname>Van Dorsselaer</surname><given-names>A.</given-names></name><name><surname>Renaud</surname><given-names>J. P.</given-names></name><name><surname>Moras</surname><given-names>D.</given-names></name><name><surname>Schule</surname><given-names>R.</given-names></name></person-group><article-title>All-trans retinoic acid is a ligand for the orphan nuclear receptor ROR &#x003b2;</article-title><source>Nat Struct Biol</source><year>2003</year><volume>10</volume><fpage>820</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">12958591</pub-id></citation></ref><ref id="r74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>S.</given-names></name><name><surname>Yokota</surname><given-names>S.</given-names></name><name><surname>Hara</surname><given-names>R.</given-names></name><name><surname>Kobayashi</surname><given-names>T.</given-names></name><name><surname>Akiyama</surname><given-names>M.</given-names></name><name><surname>Moriya</surname><given-names>T.</given-names></name><name><surname>Shibata</surname><given-names>S.</given-names></name></person-group><article-title>Physical and inflammatory stressors elevate circadian clock gene mPer1 mRNA levels in the paraventricular nucleus of the mouse</article-title><source>Endocrinology</source><year>2001</year><volume>142</volume><fpage>4910</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">11606459</pub-id></citation></ref><ref id="r102"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Torra</surname><given-names>I. P.</given-names></name><name><surname>Tsibulsky</surname><given-names>V.</given-names></name><name><surname>Delaunay</surname><given-names>F.</given-names></name><name><surname>Saladin</surname><given-names>R.</given-names></name><name><surname>Laudet</surname><given-names>V.</given-names></name><name><surname>Fruchart</surname><given-names>J. C.</given-names></name><name><surname>Kosykh</surname><given-names>V.</given-names></name><name><surname>Staels</surname><given-names>B.</given-names></name></person-group><article-title>Circadian and glucocorticoid regulation of Rev-erbalpha expression in liver</article-title><source>Endocrinology</source><year>2000</year><volume>141</volume><fpage>3799</fpage><lpage>806</lpage><pub-id pub-id-type="pmid">11014236</pub-id></citation></ref><ref id="r65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Triqueneaux</surname><given-names>G.</given-names></name><name><surname>Thenot</surname><given-names>S.</given-names></name><name><surname>Kakizawa</surname><given-names>T.</given-names></name><name><surname>Antoch</surname><given-names>M. P.</given-names></name><name><surname>Safi</surname><given-names>R.</given-names></name><name><surname>Takahashi</surname><given-names>J. S.</given-names></name><name><surname>Delaunay</surname><given-names>F.</given-names></name><name><surname>Laudet</surname><given-names>V.</given-names></name></person-group><article-title>The orphan receptor Rev-erbalpha gene is a target of the circadian clock pacemaker</article-title><source>J Mol Endocrinol</source><year>2004</year><volume>33</volume><fpage>585</fpage><lpage>608</lpage><pub-id pub-id-type="pmid">15591021</pub-id></citation></ref><ref id="r73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vgontzas</surname><given-names>A. N.</given-names></name><name><surname>Zoumakis</surname><given-names>E.</given-names></name><name><surname>Bixler</surname><given-names>E. O.</given-names></name><name><surname>Lin</surname><given-names>H. M.</given-names></name><name><surname>Follett</surname><given-names>H.</given-names></name><name><surname>Kales</surname><given-names>A.</given-names></name><name><surname>Chrousos</surname><given-names>G. P.</given-names></name></person-group><article-title>Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines</article-title><source>J Clin Endocrinol Metab</source><year>2004</year><volume>89</volume><fpage>2119</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">15126529</pub-id></citation></ref><ref id="r9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vu-Dac</surname><given-names>N.</given-names></name><name><surname>Chopin-Delannoy</surname><given-names>S.</given-names></name><name><surname>Gervois</surname><given-names>P.</given-names></name><name><surname>Bonnelye</surname><given-names>E.</given-names></name><name><surname>Martin</surname><given-names>G.</given-names></name><name><surname>Fruchart</surname><given-names>J. C.</given-names></name><name><surname>Laudet</surname><given-names>V.</given-names></name><name><surname>Staels</surname><given-names>B.</given-names></name></person-group><article-title>The nuclear receptors peroxisome proliferator-activated receptor &#x003b1; and Rev-erbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates</article-title><source>J Biol Chem</source><year>1998</year><volume>273</volume><fpage>25713</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">9748239</pub-id></citation></ref><ref id="r79"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wallenius</surname><given-names>V.</given-names></name><name><surname>Wallenius</surname><given-names>K.</given-names></name><name><surname>Ahren</surname><given-names>B.</given-names></name><name><surname>Rudling</surname><given-names>M.</given-names></name><name><surname>Carlsten</surname><given-names>H.</given-names></name><name><surname>Dickson</surname><given-names>S. L.</given-names></name><name><surname>Ohlsson</surname><given-names>C.</given-names></name><name><surname>Jansson</surname><given-names>J. O.</given-names></name></person-group><article-title>Interleukin-6-deficient mice develop mature-onset obesity</article-title><source>Nat Med</source><year>2002</year><volume>8</volume><fpage>75</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11786910</pub-id></citation></ref><ref id="r120"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Klein</surname><given-names>P. S.</given-names></name><name><surname>Lazar</surname><given-names>M. A.</given-names></name></person-group><article-title>Nuclear receptor Rev-erbalpha is a critical lithium-sensitive component of the circadian clock</article-title><source>Science</source><year>2006</year><volume>311</volume><fpage>1002</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">16484495</pub-id></citation></ref></ref-list><sec sec-type="display-objects"><title>Figures and Tables</title><fig fig-type="figure" id="fig1" position="float"><label>Figure 1</label><caption><title>Target genes of the NR1D subgroup.</title><p>&#x0201c;Rev-erbs&#x0201d; regulate gene expression events in various species and tissues. Genes listed include primary and secondary targets that have been documented in the literature. </p></caption><graphic xlink:href="nrs04009.f1"/></fig><fig fig-type="figure" id="fig2" position="float"><label>Figure 2</label><caption><title>Cross-talk between Rev-erb&#x003b1; and ROR&#x003b1; signaling in circadian gene regulation.</title><p>Rev-erb&#x003b1; and ROR&#x003b1; mutually regulate circadian Clock genes. Dysregulation in these pathways leads to chronic disease state such as metabolic syndrome.</p></caption><graphic xlink:href="nrs04009.f2"/></fig><fig fig-type="figure" id="fig3" position="float"><label>Figure 3</label><caption><title>A speculative model for ligand-dependent Rev-erb&#x003b1; modulation in mammals.</title><p>Like Drosophila, endogenous molecules such as heme and diatomic gases could possibly bind to Rev-erb&#x003b1; and activate/modulate its ability to trans-repress ROR&#x003b1; and other gene expression events.</p></caption><graphic xlink:href="nrs04009.f3"/></fig></sec></back></article> 